Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 3/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 6/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.32 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18904348 | 0.97 | HSD17B1 (0.38) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL12796384 | 0.97 | ESR1 (0.36) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL12796352 | 0.97 | ESR1 (0.36) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL13304278 | 0.97 | ESR1 (0.36) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL13304171 | 0.95 | ESR1 (0.35) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL18904372 | 0.95 | ESR1 (0.36) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL12796335 | 0.94 | GSTP1 (0.36) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL18904377 | 0.92 | ESR1 (0.37) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL18904347 | 0.92 | GSTP1 (0.37) | HSD17B1HSD17B2ESR1ESR2CYP11B1 | |
| SCHEMBL12796220 | 0.91 | HSD17B1 (0.35) | HSD17B1HSD17B2ESR1ESR2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8395144-B2 | Anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2013-03-12 | — | — | US | disclosed |
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | TRPA1, AHR, ORAI2 | HSD17B1 1663/4885HSD17B2 1523/4885ESR1 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.